STAT Plus: At a lively drug pricing debate, experts suggest killing off copays
ADOBE
A panel of policy experts and biotech veterans who gathered at Harvard on Tuesday focused much of their ire on the role of insurance.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario